Steven Girgenti
Board Member
bioAffinity Technologies, Inc. (BIAF)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Steven Girgenti
Steven Girgenti is recorded as Board Member and Chairman at bioAffinity Technologies, Inc. (BIAF). bioAffinity Technologies, Inc. reported in an 8-K filed June 5, 2024 that Steven Girgenti was appointed Director, effective June 4, 2024. bioAffinity Technologies, Inc. reported in an 8-K filed June 7, 2023 that Steven Girgenti was appointed director, effective June 6, 2023. The proxy statement of bioAffinity Technologies, Inc. reports total compensation of $261,860 for Steven Girgenti in fiscal 2025, including a base salary of $95,000. Disclosed compensation is on record for 5 fiscal years.
“The stockholders elected each of the eight director nominees to serve on the Board until the 2025 Annual Meeting of Stockholders and until such director's successor has been duly elected and qualified.”
“The stockholders elected each of the seven director nominees to serve on the Board until the 2024 Annual Meeting of Stockholders and until such director's successor has been duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-04–present
-
Current
2014-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at bioAffinity Technologies, Inc.
Other people whose current roles at this company are on record from its filings.
- Maria Zannes CEO, Board Member
- J. Michael Edwards CFO
- James Michael Edwards CFO
- Michael Dougherty CFO
- Xavier Reveles COO
- Timothy P. Zannes General Counsel
- Gary Rubin Board Member
- Jamie Platt Board Member
- Jamie Platt, Ph.D. Board Member
- Jamie Platt, PhD Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | bioAffinity Technologies, Inc. (BIAF) | Executive Chairman | $95,000 | $261,860 |
| 2024 | bioAffinity Technologies, Inc. (BIAF) | Executive Chairman | $95,000 | $366,679 |
| 2023 | bioAffinity Technologies, Inc. (BIAF) | Executive Chairman | $95,000 | $248,745 |
| 2022 | bioAffinity Technologies, Inc. (BIAF) | Executive Chairman | $93,333 | $153,333 |
| 2021 | bioAffinity Technologies, Inc. (BIAF) | Executive Chairman | $60,000 | $193,222 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.